Annual Pharma Summit 2024

India's pharmaceutical sector, currently valued at USD 50 billion, is one of the fastest-growing industries in the country. It is expected to reach USD 65 billion by 2024 and anticipated to double its value to USD 130 billion by 2030. The sector plays a prominent role in the global pharmaceutical industry.

While India has made rapid progress in manufacturing and exporting generic drugs, it still imports the majority of the APIs and KSMs for drug manufacturing. One of the major reasons attributing to higher imports is the lack of sufficient investments towards Research and Development (R&D) by the Pharma sector, apart from other sectors in India. India's overall expenditure on R&D stood at 0.8% of its GDP in 2021, which is among the lowest in the world.

With this context, ASSOCHAM is organizing its 'Annual Pharma Summit 2024' themed “Positioning India as the Pharmaceutical Innovation Hub” to assimilate key expectations of the Indian Pharma industry with a focus on Research and Development.

Key area of discussions

• PRIP (Promotion of Research and Innovation in Pharma MedTech Sector): India opportunities for investments
• Driving Business growth: Building a conducive ecosystem for Innovation and Product Development

ASSOCHAM Pharma Excellence Awards 2023-24 (Categories)